About
ARKG is an actively managed fund that targets companies involved in the genomics industry.
- Name
- ARK Genomic Revolution ETF
- Index tracked
- S&P 500 (TR) (1970)
- Type
- Equity
- Expense ratio
- 0.75%
- Management fee
- 0.75%
- Dividend policy
- Annually
- NAV
- USD 44.304 (08/13/2026)
- Issued units
- 39.40M (08/14/2026)
- Listing date
- Oct 31, 2014
- Sponsor
- ARK ETF Trust
- Custodian
- The Bank of New York Mellon